Product
Fortesta
Aliases
FORTESTA
Name
FORTESTA
2 clinical trials
1 drug
4 indications
Indication
HypogonadismIndication
maleIndication
hypogonadotropic hypogonadismIndication
Gender DysphoriaClinical trial
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Administration With Marketed Testosterone ProductsStatus: Completed, Estimated PCD: 2023-07-12
Clinical trial
The Effect on Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population on Bone Density, Fractures, Memory/Cognitive Function and Qualities of LifeStatus: Recruiting, Estimated PCD: 2025-01-01